USD10
OCUL Shares
About Ocular TherapeutixOcular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
USD10
OCUL Shares
About Ocular TherapeutixOcular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$1.97B
OPEN PRICE
$9.07
LOW (1Y)
$6.23
HIGH (1Y)
$16.44
LOW (24H)
$8.81
HIGH (24H)
$9.22
VOLUME (24H)
$1.88M
30.84%
Price history
Time | Price | Change |
|---|---|---|
Today | $9.07 | |
1 Day | $8.97 | |
1 Week | $10.20 | |
1 Month | $9.42 | |
1 Year | $11.52 |
Past performance is not a reliable indicator of future results.
Discover more
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.